HIV Therapeutics

Journal of antivirals & antiretrovirals is one of the simplest peer-reviewed journals within the field of virology. Articles published during this peer-reviewed journal are properly reviewed by the simplest faculty reviewers at the associated fields HIV Therapeutics is especially focused on finding new and effective therapies that include drug class, and antiretroviral drug combinations which will extend and improve the standard of life for people infected with HIV/AIDS and associated co-infections and complications. It mainly supports research that advances our understanding of HIV and the way it causes disease, thereby unlocking new targets for drug development. The goal is to spot new drugs that are less toxic with fewer side effects, promote better adherence, and are readily accessible, particularly in resource-limited settings. Promising medicines are tested in human clinical trials to work out whether or not they are safe and effective. OMICS journals follow single-blind reviewing process, during which the reviewer is obscure to the author, but the identity of the author is understood to the reviewer. An article board asks subject experts to review, assess and evaluate submitted articles before accepting them for publication during a scholarly journal. Submissions are evaluated using criteria like the originality of the work, excellence, novelty and significance of the research or thoughts and respect for copy rights. Scholarly open access journals use this referee process to make sure and maintain the standard of fabric they publish and for his or her scholastic notoriety.    

High Impact List of Articles

Relevant Topics in Medical